$0.8779
0.0003[0.03%]
At close: May 3
$0.8779
0[0.00%]
PreMarket: 5:50AM EDT
OptiNose
(NASDAQ:OPTN)Latest News for OptiNose Stock (NASDAQ:OPTN)
OptiNose Stock (NASDAQ: OPTN)
Categories: All
Monday, April 29, 2024
Thursday, April 25, 2024
- Why Caterpillar Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionAvi Kapoor - Apr 25, 2024, 1:57PM
- Market-Moving News for April 25thBenzinga Newsdesk - Apr 25, 2024, 8:31AM
- Optinose Provides Corporate Updates; Expects To Produce Positive Income From Operations For Full Year 2025Benzinga Newsdesk - Apr 25, 2024, 7:29AM
Monday, April 22, 2024
Monday, March 18, 2024
Friday, March 15, 2024
- 12 Health Care Stocks Moving In Friday's After-Market SessionBenzinga Insights - Mar 15, 2024, 5:33PM
- OptiNose Shares Resume TradeHappy Mohamed - Mar 15, 2024, 4:20PM
- Trading Halt: Halt status updated at 4:15:00 PM ET: Quotation Resumption: News and Resumption TimesBenzinga Newsdesk - Mar 15, 2024, 4:15PM
- Optinose Announces That FDA Approved XHANCE Nasal Spray For The Treatment Of Chronic Rhinosinusitis Without Nasal Polyps In Patients 18 Years Of Age And OlderBenzinga Newsdesk - Mar 15, 2024, 3:37PM
- Trading Halt: Halted at 3:26:16 p.m. ET - Trading Halt: Halt News PendingBenzinga Newsdesk - Mar 15, 2024, 3:26PM
Monday, March 11, 2024
Thursday, March 07, 2024
- Optinose Reports Fourth Quarter And Full Year 2023 Xhance Net Revenue Of $19.9M And $71MBenzinga Newsdesk - Mar 7, 2024, 7:06AM
- OptiNose Q4 GAAP EPS $(0.09), Inline, Sales $19.86M Beat $19.23M EstimateBenzinga Newsdesk - Mar 7, 2024, 7:05AM
- Earnings Scheduled For March 7, 2024Benzinga Insights - Mar 7, 2024, 4:49AM
Wednesday, March 06, 2024
Thursday, January 18, 2024
Wednesday, December 06, 2023
- 12 Health Care Stocks Moving In Wednesday's After-Market SessionBenzinga Insights - Dec 6, 2023, 4:31PM
- Gold Moves Higher; Campbell Soup Earnings Top ExpectationsLisa Levin - Dec 6, 2023, 2:45PM
- Why AeroVironment Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionLisa Levin - Dec 6, 2023, 2:43PM
- 12 Health Care Stocks Moving In Wednesday's Intraday SessionBenzinga Insights - Dec 6, 2023, 12:31PM
- Crude Oil Down 4%; Pharvaris Shares Spike HigherLisa Levin - Dec 6, 2023, 12:29PM
- OptiNose shares are trading lower after the company announced that the FDA extended the review period for the supplemental new drug application of XHANCE by three months.Benzinga Newsdesk - Dec 6, 2023, 11:57AM
- US Stocks Higher; Private Payrolls Rise By 103,000 In NovemberLisa Levin - Dec 6, 2023, 9:42AM
- Why ENT-Focused OptiNose Shares Are Diving TodayNabaparna Bhattacharya - Dec 6, 2023, 9:21AM
- 12 Health Care Stocks Moving In Wednesday's Pre-Market SessionBenzinga Insights - Dec 6, 2023, 8:06AM
- Optinose Reports 3-Month Extension Of FDA Review Period For Supplemental New Drug Application For XHANCEBenzinga Newsdesk - Dec 6, 2023, 7:45AM
Thursday, November 09, 2023
- OptiNose, Inc Expects FY23 XHANCE Net Revenues of $66.0M-$70.0M (Prior $64.0M-$70.0M)Benzinga Newsdesk - Nov 9, 2023, 7:15AM
- OptiNose Q3 EPS $(0.08) Vs $(0.18) YoY, Sales $19.82M Beat $18.68M EstimateBenzinga Newsdesk - Nov 9, 2023, 7:01AM
- Earnings Scheduled For November 9, 2023Benzinga Insights - Nov 9, 2023, 6:52AM
Monday, August 21, 2023
Friday, August 11, 2023
Thursday, August 10, 2023
- OptiNose Expects FY23 XHANCE Net Revenues Of $64M-$70M (Prior View: $62M-$68M)Benzinga Newsdesk - Aug 10, 2023, 7:18AM
- OptiNose Q2 EPS $0.02 Beats $(0.11) Estimate, Sales $19.45M Beat $17.36M EstimateBenzinga Newsdesk - Aug 10, 2023, 7:03AM
- Earnings Scheduled For August 10, 2023Benzinga Insights - Aug 10, 2023, 6:59AM
Friday, July 28, 2023
Thursday, July 27, 2023
Monday, July 10, 2023
Wednesday, June 07, 2023
Tuesday, June 06, 2023
Wednesday, May 31, 2023
Monday, May 22, 2023
Friday, May 19, 2023
Thursday, May 11, 2023
- Earnings Scheduled For May 11, 2023Benzinga Insights - May 11, 2023, 9:58AM
- Optinose Expects XHANCE Net Revenues For 2023 Of $62.0M-$68.0MBenzinga Newsdesk - May 11, 2023, 7:08AM
- OptiNose Q1 EPS $(0.17) Vs. $(0.31) Last Year, Sales $11.85M Beat $9.95M EstimateBenzinga Newsdesk - May 11, 2023, 7:06AM
- Recap: OptiNose Q1 EarningsBenzinga Insights - May 11, 2023, 7:05AM